Long-term update of the 24954 EORTC phase III trial on larynx preservation

被引:26
作者
De Figueiredo, B. Henriques [1 ]
Fortpied, C. [2 ]
Menis, J. [2 ]
Lefebvre, J. L. [3 ]
Barzan, L. [4 ]
de Raucourt, D. [5 ]
Geoffrois, L. [6 ]
Giurgea, L. [2 ]
Hupperets, P. [7 ]
Leemans, C. R. [8 ]
Licitra, L. [9 ]
Rolland, F. [10 ]
Tesselaar, M. [11 ]
Vermorken, J. B. [12 ]
Gregoire, V. [1 ]
机构
[1] Catholic Univ Louvain, St Luc Univ Hosp, Dept Radiat Oncol, Inst Rech Expt & Clin, Brussels, Belgium
[2] EORTC Headquarters, Brussels, Belgium
[3] Ctr Oscar Lambret, Dept Head & Neck Canc, Lille, France
[4] Ctr Riferimento Oncol, Dept Surg, Aviano, Italy
[5] Ctr Francois Baclesse, Dept Head & Neck Surg, Caen, France
[6] Ctr Alexis Vautrin, Dept Med Oncol, Nancy, France
[7] Univ Hosp, Dept Internal Med, Maastricht, Netherlands
[8] Vrije Univ Amsterdam, Ctr Canc, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
[9] Fdn IRCCS Ist Tumori, Dept Head & Neck Med Oncol, Milan, Italy
[10] Inst Cancerol Ouest, Dept Oncol, Nantes, France
[11] Univ Hosp, Dept Radiotherapy, Leiden, Netherlands
[12] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
关键词
Larynx preservation; Radiochemotherapy; Late toxicity; CHEMOTHERAPY; CANCER; HEAD;
D O I
10.1016/j.ejca.2016.06.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The long-term results of the EORTC 24954 trial comparing sequential versus alternating chemotherapy and radiotherapy (RT) for patients with locally advanced laryngeal and hypopharyngeal cancer are reported. From 1996 to 2004, 450 patients were randomly assigned (1-1) to a sequential arm (SA = induction cisplatin-5fluorouracil followed by a 70Gy-RT for the responders or a total laryngectomy and post-operative RT for the non-responders) and an alternating arm (AA = cisplatin-5fluorouracil alternated with three 2-week courses of 20 Gy-RT for a total dose of 60 Gy). Median follow-up was 10.2 years. Ten-year survival with functional larynx (primary end-point) and overall survival were similar in both arms (18.7% and 33.6% in SA versus 18.3% and 31.6% in AA). Late toxicity was also similar; however, a trend for higher larynx preservation and better laryngeal function was observed in AA. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:109 / 112
页数:4
相关论文
共 6 条
  • [1] Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
    Blanchard, Pierre
    Bourhis, Jean
    Lacas, Benjamin
    Posner, Marshall R.
    Vermorken, Jan B.
    Cruz Hernandez, Juan J.
    Bourredjem, Abderrahmane
    Calais, Gilles
    Paccagnella, Adriano
    Hitt, Ricardo
    Pignon, Jean-Pierre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2854 - +
  • [2] Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
    Forastiere, Arlene A.
    Zhang, Qiang
    Weber, Randal S.
    Maor, Moshe H.
    Goepfert, Helmuth
    Pajak, Thomas F.
    Morrison, William
    Glisson, Bonnie
    Trotti, Andy
    Ridge, John A.
    Thorstad, Wade
    Wagner, Henry
    Ensley, John F.
    Cooper, Jay S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 845 - 852
  • [3] Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
    Lefebvre, J. L.
    Rolland, F.
    Tesselaar, M.
    Bardet, E.
    Leemans, C. R.
    Geoffrois, L.
    Hupperets, P.
    Barzan, L.
    de Raucourt, D.
    Chevalier, D.
    Licitra, L.
    Lunghi, F.
    Stupp, R.
    Lacombe, D.
    Bogaerts, J.
    Horiot, J. C.
    Bernier, J.
    Vermorken, J. B.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (03): : 142 - 152
  • [4] Larynx preservation in pyriform sinus cancer: Preliminary results of a European organization for research and treatment of cancer phase III trial
    Lefebvre, JL
    Chevalier, D
    Luboinski, B
    Kirkpatrick, A
    Collette, L
    Sahmoud, T
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (13) : 890 - 899
  • [5] Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data
    Pignon, JP
    Bourhis, J
    Domenge, C
    Designé, L
    [J]. LANCET, 2000, 355 (9208) : 949 - 955